Is Cardinal Health (CAH) a Great Value Stock Right Now?
Werte in diesem Artikel
The proven Zacks Rank system focuses on earnings estimates and estimate revisions to find winning stocks. Nevertheless, we know that our readers all have their own perspectives, so we are always looking at the latest trends in value, growth, and momentum to find strong picks.Of these, value investing is easily one of the most popular ways to find great stocks in any market environment. Value investors rely on traditional forms of analysis on key valuation metrics to find stocks that they believe are undervalued, leaving room for profits.Zacks has developed the innovative Style Scores system to highlight stocks with specific traits. For example, value investors will be interested in stocks with great grades in the "Value" category. When paired with a high Zacks Rank, "A" grades in the Value category are among the strongest value stocks on the market today.One company value investors might notice is Cardinal Health (CAH). CAH is currently sporting a Zacks Rank of #2 (Buy) and an A for Value. The stock has a Forward P/E ratio of 14.40. This compares to its industry's average Forward P/E of 17.29. Over the past year, CAH's Forward P/E has been as high as 15.59 and as low as 12.37, with a median of 14.08.Investors will also notice that CAH has a PEG ratio of 1.41. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. CAH's PEG compares to its industry's average PEG of 1.97. Within the past year, CAH's PEG has been as high as 1.55 and as low as 0.86, with a median of 1.07.Finally, investors will want to recognize that CAH has a P/CF ratio of 14.47. This figure highlights a company's operating cash flow and can be used to find firms that are undervalued when considering their impressive cash outlook. CAH's P/CF compares to its industry's average P/CF of 18.48. Over the past 52 weeks, CAH's P/CF has been as high as 29.98 and as low as 13.22, with a median of 18.31.Investors could also keep in mind McKesson (MCK), an Medical - Dental Supplies stock with a Zacks Rank of # 1 (Strong Buy) and Value grade of A.Shares of McKesson currently holds a Forward P/E ratio of 16.24, and its PEG ratio is 1.15. In comparison, its industry sports average P/E and PEG ratios of 17.29 and 1.97.MCK's price-to-earnings ratio has been as high as 19.54 and as low as 14.23, with a median of 16.92, while its PEG ratio has been as high as 1.65 and as low as 1.06, with a median of 1.34, all within the past year.McKesson also has a P/B ratio of -27.69 compared to its industry's price-to-book ratio of 4.56. Over the past year, its P/B ratio has been as high as -23.17, as low as -59.19, with a median of -42.46.These are only a few of the key metrics included in Cardinal Health and McKesson strong Value grade, but they help show that the stocks are likely undervalued right now. When factoring in the strength of its earnings outlook, CAH and MCK look like an impressive value stock at the moment.7 Best Stocks for the Next 30 DaysJust released: Experts distill 7 elite stocks from the current list of 220 Zacks Rank #1 Strong Buys. They deem these tickers "Most Likely for Early Price Pops."Since 1988, the full list has beaten the market more than 2X over with an average gain of +24.1% per year. So be sure to give these hand picked 7 your immediate attention. See them now >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Cardinal Health, Inc. (CAH): Free Stock Analysis Report McKesson Corporation (MCK): Free Stock Analysis ReportTo read this article on Zacks.com click here.Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks
Ausgewählte Hebelprodukte auf Cardinal
Mit Knock-outs können spekulative Anleger überproportional an Kursbewegungen partizipieren. Wählen Sie einfach den gewünschten Hebel und wir zeigen Ihnen passende Open-End Produkte auf Cardinal
Der Hebel muss zwischen 2 und 20 liegen
Name | Hebel | KO | Emittent |
---|
Name | Hebel | KO | Emittent |
---|
Quelle: Zacks
Nachrichten zu Cardinal Health Inc.
Analysen zu Cardinal Health Inc.
Datum | Rating | Analyst | |
---|---|---|---|
08.03.2018 | Cardinal Health Equal Weight | Barclays Capital | |
04.12.2017 | Cardinal Health Hold | Deutsche Bank AG | |
19.09.2017 | Cardinal Health Sector Perform | RBC Capital Markets | |
28.04.2017 | Cardinal Health Neutral | Tigress Financial | |
04.04.2017 | Cardinal Health Hold | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
03.11.2015 | Cardinal Health Buy | UBS AG | |
03.11.2015 | Cardinal Health Outperform | FBR Capital | |
09.06.2015 | Cardinal Health Buy | UBS AG | |
10.03.2015 | Cardinal Health Outperform | FBR Capital | |
04.03.2015 | Cardinal Health Outperform | RBC Capital Markets |
Datum | Rating | Analyst | |
---|---|---|---|
08.03.2018 | Cardinal Health Equal Weight | Barclays Capital | |
04.12.2017 | Cardinal Health Hold | Deutsche Bank AG | |
19.09.2017 | Cardinal Health Sector Perform | RBC Capital Markets | |
28.04.2017 | Cardinal Health Neutral | Tigress Financial | |
04.04.2017 | Cardinal Health Hold | Needham & Company, LLC |
Datum | Rating | Analyst | |
---|---|---|---|
Keine Analysen im Zeitraum eines Jahres in dieser Kategorie verfügbar. Eventuell finden Sie Nachrichten die älter als ein Jahr sind im Archiv |
Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Cardinal Health Inc. nach folgenden Kriterien zu filtern.
Alle: Alle Empfehlungen